Regional TMPRSS2 V197M Allele Frequencies Are Correlated with COVID-19 Case Fatality Rates.
Korean Society for Molecular and Cellular Biology
MetadataShow full item record
Jeon, S., Blazyte, A., Yoon, C., Ryu, H., Jeon, Y., Bhak, Y., Bolser, D., et al. (2021). Regional TMPRSS2 V197M Allele Frequencies Are Correlated with COVID-19 Case Fatality Rates.. Mol Cells, 44 (9), 680-687. https://doi.org/10.14348/molcells.2021.2249
Coronavirus disease, COVID-19 (coronavirus disease 2019), caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has a higher case fatality rate in European countries than in others, especially East Asian ones. One potential explanation for this regional difference is the diversity of the viral infection efficiency. Here, we analyzed the allele frequencies of a nonsynonymous variant rs12329760 (V197M) in the TMPRSS2 gene, a key enzyme essential for viral infection and found a significant association between the COVID-19 case fatality rate and the V197M allele frequencies, using over 200,000 present-day and ancient genomic samples. East Asian countries have higher V197M allele frequencies than other regions, including European countries which correlates to their lower case fatality rates. Structural and energy calculation analysis of the V197M amino acid change showed that it destabilizes the TMPRSS2 protein, possibly negatively affecting its ACE2 and viral spike protein processing.
COVID-19, SARS-CoV-2, TMPRSS2, allele frequency, case fatality rate, Asian People, COVID-19, Gene Frequency, Humans, Models, Molecular, Mortality, Polymorphism, Single Nucleotide, Republic of Korea, Serine Endopeptidases, White People
External DOI: https://doi.org/10.14348/molcells.2021.2249
This record's URL: https://www.repository.cam.ac.uk/handle/1810/330520
Attribution-NonCommercial-ShareAlike 4.0 International
Licence URL: https://creativecommons.org/licenses/by-nc-sa/4.0/
Recommended or similar items
The current recommendation prototype on the Apollo Repository will be turned off on 03 February 2023. Although the pilot has been fruitful for both parties, the service provider IKVA is focusing on horizon scanning products and so the recommender service can no longer be supported. We recognise the importance of recommender services in supporting research discovery and are evaluating offerings from other service providers. If you would like to offer feedback on this decision please contact us on: firstname.lastname@example.org